Saad S. Kenderian, MB, ChB

Department of Hematology, Mayo Clinic

Poster(s):

• 1502 - Sequencing single novel agent-based therapy for patients with CLL: A retrospective study of patients treated with covalent Bruton Tyrosine Kinase inhibitor (cBTKi) followed by B-cell lymphoma 2 inhibitor (BCL2i) versus BCL2i followed by cBTKi

• 1601 - Central Nervous System Involvement in Patients with Richter Transformation